InSiGa Technologies and POET to Demonstrate Laser Driver and Optical Engine Combinations for 800G and 1.6T Optical Modules at CIOE
September 11, 2024 07:00 ET
|
POET Technologies Inc.
TORONTO and SHENZHEN, CHINA, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Chengdu InSiGa Semiconductor Technologies Co., Ltd. (“InSiGa”) and POET Technologies Inc. (“POET”) (TSX Venture: PTK; NASDAQ: POET),...
Agios Announces FDA Orphan Drug Designation Granted to Tebapivat (AG-946) for Treatment of Myelodysplastic Syndromes (MDS)
September 11, 2024 07:00 ET
|
Agios Pharmaceuticals, Inc.
Agios today announced that the FDA has granted orphan drug designation to tebapivat (AG-946) for the treatment of myelodysplastic syndromes (MDS).
TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVID
September 11, 2024 07:00 ET
|
TFF Pharmaceuticals, Inc.
Partnership funded by BARDA and other US government agencies TFF formulation may provide flexibility of delivery and improve storage and distribution conditions FORT WORTH, Texas, Sept. 11, 2024 ...
ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger
September 11, 2024 06:50 ET
|
ANI Pharmaceuticals, Inc.; Alimera Sciences, Inc.
PRINCETON, N.J. and ATLANTA, Sept. 11, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) (“ANI”) and Alimera Sciences, Inc. (NASDAQ: ALIM) (“Alimera” or the “Company”) today jointly...
Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC
September 11, 2024 06:30 ET
|
Sanara MedTech Inc.
FORT WORTH, TX, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical...
The Atrisco Solar & Storage Project Has Commenced Commercial Operations
September 11, 2024 06:01 ET
|
Enlight Renewable Energy Ltd.
TEL AVIV, Israel, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Enlight Renewable Energy (“Enlight”, "the Company”, NASDAQ: ENLT, TASE: ENLT.TA), a leading renewable energy platform, announces the initial...
Dupixent® (dupilumab) Phase 3 Trial Confirms Significant Improvements in Itch and Hives for Patients with Chronic Spontaneous Urticaria (CSU)
September 11, 2024 01:04 ET
|
Regeneron Pharmaceuticals, Inc.
Confirming the results of Study A, this second pivotal trial in biologic-naïve patients met primary and key secondary endpoints, showing treatment with Dupixent resulted in a nearly 50% reduction in...
Dupixent® (dupilumab) Is the First and Only Biologic to Achieve Significant Improvements in Disease Remission and Symptoms in Bullous Pemphigoid (BP) Positive Pivotal Trial
September 11, 2024 00:59 ET
|
Regeneron Pharmaceuticals, Inc.
Trial met the primary and all key secondary endpoints in adults with moderate-to-severe disease; five times more patients achieved sustained disease remission with Dupixent than placebo Dupixent is...
Terns Announces Pricing of Upsized $150.15 Million Public Offering
September 10, 2024 22:50 ET
|
Terns Pharmaceuticals, Inc.
FOSTER CITY, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...
SIMPPLE Australia Pty Ltd Launches Cutting-Edge Robots and Software into Australian and New Zealand markets at the Sydney ISSA Cleaning & Hygiene Expo 2024
September 10, 2024 21:47 ET
|
Simpple Ltd.
SIMPPLE Australia Pty. Ltd. launches its latest product line-up of robotic solutions (SIMPPLE Robotics) in the Australia and New Zealand (ANZ) market.